PRDM2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.780000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.407200E-01
Normal-vs-Stage2
2.869200E-01
Normal-vs-Stage3
1.050250E-01
Normal-vs-Stage4
4.370400E-01
Stage1-vs-Stage2
4.456200E-01
Stage1-vs-Stage3
6.673600E-01
Stage1-vs-Stage4
5.788200E-02
Stage2-vs-Stage3
2.789000E-01
Stage2-vs-Stage4
1.107610E-01
Stage3-vs-Stage4
8.434100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.763600E-01
Normal-vs-AfricanAmerican
1.040640E-01
Normal-vs-Asian
1.068230E-01
Caucasian-vs-AfricanAmerican
9.249000E-01
Caucasian-vs-Asian
8.985400E-01
AfricanAmerican-vs-Asian
9.755400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.653800E-01
Normal-vs-Female
2.978600E-01
Male-vs-Female
2.520000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.879450E-01
Normal-vs-Age(41-60Yrs)
3.387000E-01
Normal-vs-Age(61-80Yrs)
2.605400E-01
Normal-vs-Age(81-100Yrs)
2.323600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.012600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.988400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.238000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.943760E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.513600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.133000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.738800E-03
Normal-vs-Daily Drinker
2.659800E-01
Normal-vs-Weekly Drinker
2.854000E-02
Normal-vs-Occasional Drinker
2.910800E-01
Normal-vs-Social Drinker
2.829000E-01
Non Drinker-vs-Daily Drinker
3.600200E-01
Non Drinker-vs-Weekly Drinker
4.135200E-01
Non Drinker-vs-Occasional Drinker
2.182800E-01
Non Drinker-vs-Social Drinker
3.089000E-01
Daily Drinker-vs-Weekly Drinker
9.153800E-01
Daily Drinker-vs-Occasional Drinker
6.332200E-01
Daily Drinker-vs-Social Drinker
7.709000E-01
Weekly Drinker-vs-Occasional Drinker
7.782600E-01
Weekly Drinker-vs-Social Drinker
8.903400E-01
Occasional Drinker-vs-Social Drinker
8.795600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.444000E-01
Normal-vs-Grade 2
7.117200E-01
Normal-vs-Grade 3
8.126000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.717900E-02
Grade 1-vs-Grade 3
7.145400E-01
Grade 1-vs-Grade 4
6.444000E-01
Grade 2-vs-Grade 3
4.972200E-02
Grade 2-vs-Grade 4
7.117200E-01
Grade 3-vs-Grade 4
8.126000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.725000E-01
Normal-vs-NonDiabetic
2.616600E-01
Diabetic-vs-NonDiabetic
7.737400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.795400E-01
Normal-vs-NoPancreatitis
2.664600E-01
Pancreatitis-vs-NoPancreatitis
8.698400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.573400E-01
Normal-vs-N1
2.872400E-01
N0-vs-N1
2.909800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.506200E-01
Normal-vs-TP53-NonMutant
1.799950E-02
TP53-Mutant-vs-TP53-NonMutant
9.145200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
